Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Van Goethem

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 8, 2017
MicroRNA Expression Analysis Using Small RNA Sequencing Discovery and RT-qPCR-Based ValidationAlan Van Goethem, Pieter Mestdagh, Tom Van Maerken, et al.
Cancer Letters|November 23, 2013
Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancerTom Van Maerken, Ali Rihani, Alan Van Goethem, et al.
Oncotarget|September 17, 2017
Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastomaAlan Van Goethem, Nurten Yigit, Myrthala Moreno-Smith, et al.
Database : the Journal of Biological Databases and Curation|August 27, 2014
miRBase Tracker: keeping track of microRNA annotation changesGert Van Peer, Steve Lefever, Jasper Anckaert, et al.
Scientific Reports|December 1, 2016
Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samplesAlan Van Goethem, Nurten Yigit, Celine Everaert, et al.
Scientific Reports|March 13, 2015
Genome wide expression profiling of p53 regulated miRNAs in neuroblastomaAli Rihani, Alan Van Goethem, Maté Ongenaert, et al.
NAR Cancer|January 23, 2023
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivationAlan Van Goethem, Jill Deleu, Nurten Yigit, et al.
JCI Insight|December 7, 2018
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patientsFjoralba Zeka, Anneleen Decock, Alan Van Goethem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2015
Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted TreatmentIrina Lambertz, Candy Kumps, Shana Claeys, et al.
Nature Methods|March 1, 2017
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research, Jan Van Deun, Pieter Mestdagh, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|October 8, 2017
MicroRNA Expression Analysis Using Small RNA Sequencing Discovery and RT-qPCR-Based ValidationAlan Van Goethem, Pieter Mestdagh, Tom Van Maerken, et al.
Cancer Letters|November 23, 2013
Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancerTom Van Maerken, Ali Rihani, Alan Van Goethem, et al.
Oncotarget|September 17, 2017
Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastomaAlan Van Goethem, Nurten Yigit, Myrthala Moreno-Smith, et al.
Database : the Journal of Biological Databases and Curation|August 27, 2014
miRBase Tracker: keeping track of microRNA annotation changesGert Van Peer, Steve Lefever, Jasper Anckaert, et al.
Scientific Reports|December 1, 2016
Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samplesAlan Van Goethem, Nurten Yigit, Celine Everaert, et al.
Scientific Reports|March 13, 2015
Genome wide expression profiling of p53 regulated miRNAs in neuroblastomaAli Rihani, Alan Van Goethem, Maté Ongenaert, et al.
NAR Cancer|January 23, 2023
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivationAlan Van Goethem, Jill Deleu, Nurten Yigit, et al.
JCI Insight|December 7, 2018
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patientsFjoralba Zeka, Anneleen Decock, Alan Van Goethem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2015
Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted TreatmentIrina Lambertz, Candy Kumps, Shana Claeys, et al.
Nature Methods|March 1, 2017
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research, Jan Van Deun, Pieter Mestdagh, et al.
Pageof 1